Replies to post #207288 on Innovation Pharmaceuticals Inc (IPIX)

[Jewelsoftheworld]

Your comments and insight are appreciated. Thank you.

[1hb]

Excellent Biohedge Excellent. As you have said for past year or so. I felt 20-30 cents with partner if equaled interim look and it was discounted with report that came out. So when results did not equal the halfway point or whatever time was results it pulled back into base area..Now results were still very, very good or even great however not the super duper earlier ones. Simple math applied to results would say that out of every 1000 patients 600 on placebo or no treatment will experience severe Oral Mucositis verses only 368 that take brilacidin. So that is a walloping 232 LESS patients saving how many lives? 15 -45? we need to research and figure that.
With K and P results in next 60 days and probable partnerships during the same 60 days stock should have a chance to get to 5 or 10 or higher and even at 5 get listed and add fund buying value that way too....

[top123]

Bio - "IPIX is making real progress and as soon as a deal or two are inked, the investment profile will change significantly."

Thank for all your post and I truly value your input, know your science and yet conservative in projections and i really like that, having said that given the the P2 results and assuming and IF we get just decent results on secondary - What are the chances of getting a deal with BP/Partners?

Thank you.

[sox040713]

IPIX is traded on the wild wild west of stock exchange. Investors can't live in this area without hearing some gunshots.

That is one of the problems with the OTC stocks. They are prone to massive swings due to the lack of institutional buyers.

[To infinity and beyond!]

it would seem the market response to the trial news -loss of 25% of value, and back to recent lows- is exaggerated. Results are certainly fine to move forward with, and the value of brilacidin remains high.

Would the same sell-off occur for better results? Just sell the news, no matter what?

Agree that the science keeps moving forward. Unfortunately must also agree with plenty paranoid that big pharma has more leverage now in bidding rather than less, and this hurts the company in the short run

another concern of course is prurisol. With an unsuccessful trial the short run will be considerably more bleak